5 September 2022
RDM researchers tested the method in COVID-19 patients, to find that the results predicted in-hospital mortality.
6 July 2022
Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.
Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease
1 December 2021
Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.
21 October 2021
Study investigating the long-term impact of moderate to severe COVID-19 finds that a large proportion of COVID-19 patients previously admitted to hospital continue to experience intrusive symptoms six months following infection.
15 September 2021
Updated: the project, involving Oxford University Hospitals, Defence Medical Services (DMS), and the Radcliffe Department of Medicine was 'highly commended' at the Health Service Journal Awards 2021.
10 June 2021
Scientists from the MRC Weatherall Institute of Molecular Medicine have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.